Postdoctoral Fellow-MSH
- Location
- New York, NY
- Posted
- 1763 days ago
How well does your resume fit this job?
Upload your resume to see your score for this Mount Sinai Health System role, what matches, what's missing, and your best other matches.
Scored on our server and not saved there. The file stays in this browser so you don't have to upload it again after you sign up.
Roles & Responsibilities
Multiple postdoctoral positions are immediately available in Shi laboratory of Proteomics, Center for Protein Engineering and Therapeutics at Icahn School of Medicine at Mount Sinai in NYC
The lab is interested in developing biotechnologies for the analysis of biomolecules and macromolecular assemblies, with a focus on mass spectrometry/proteomic techniques. Recently, inspired by the high translational potential of the camelid single-chain antibodies (so called nanobodies), our lab has developed robust pipeline technologies and tools to facilitate nanobody drug discovery and therapeutic applications.
The lab is also interested in the development and application of integrative structural approaches to study protein-protein and antibody-protein interactions. An emerging direction of the lab is to conjugate machine learning, structural biology and proteomic approaches to facilitate engineering and design towards novel protein therapeutics and vaccine development.
The lab is vibrant, fun, and collaborative and support creative ideas and career development.
References
- Kim, S.J., et al (2018).
- Integrative structure and functional anatomy of a nuclear pore complex.
- Nature.
- Xiang, Y., et al (2020).
- Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.
- Science.
- Nambulli., et al (2021).
- Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.
- Science Advances.
- Xiang, Y., et al (2021).
- Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies.
- Cell Systems.
- Sun, et al.
- (2021).
- Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes.
- Nature Communications.
- Shen et al.
- (2021).
- A resource of high-quality nanobodies for drug delivery. iScience.
- Sang, et al.
- (2021) Llamanade: an open-source computational pipeline for robust nanobody humanization.
- Structure.
- Xiang et al (2022).
- Super-immunity by broadly protective nanobodies to sarbecoviruses.
- BioRxiv.
The lab is funded by multiple grants including the NIH, AAZ and MJFF. Competitive salaries can be provided for successful candidates.
Some related news are list here
- Inhaled nanobodies effective against coronaviurs in hamsters, researchers say (Fox News)
- Llama 'nanobodies’ may yield COVID-19 treatment, Pitt scientists say (The Philadelphia Inquirer)
- Why the lovable llama might be a secret weapon against COVID-19 (Argonne National Library)
- Nasal spray gives Pitt researchers a promising new weapon to fight COVID (Next Pittsburgh)
- Pitt Researchers Discover Llama ‘Nanobodies’ Are Powerful New Coronavirus Treatment (CBS Local)
- Pitt team discovers new way to find nanbodies to fight disease (WPXI)
- Pitt scientists unveil potential 'powerful' treatment for COVID-19 using llama nanobodies (WJAC)
- Pitt researchers say llamas may help research and treatment of COVID (WTAE)
- Alpacas and llamas may hold the key to alternative COVID-19 vaccine (Fox 8)
- Llama antibodies? Why researchers say they could be powerful weapon against COVID-19 (ABC 7)
- Researchers hope to harness power of llama nanobodies to treat coronavirus (Fox 43)
- Inhaled antibody fragments protect infected animals against COVID-19 (The Scientist)
- Inhalable nanobody shows potent anti-SARS-CoV2 activity in vivo (Medical.net)
- Scientists Cure COVID in Hamsters With Inhaled Nanobodies: Study (Gadgets 360)
- Llama nanobodes are a powerful bew COVID-19 treatment: Study (The New York Post)
- Asthma style inhalter of tiny nanobodies cleared COVID infection in hamsters (Daily Mail UK)
- Inhaled COVID Meds and 'Simple, Self-Administered' Care (Medscape)
- Neutralizing nanobodies effective against SARS-CoV2 variants (Medical.net)
Requirements
Motivated individuals (PhD or MD) with a background in mass spectrometry-based proteomics, microbiology, structural biology (such as cryo-EM), and cancer immunology (ideally with animal model experience) are particularly welcome to apply. Interested candidates may submit their CV, including names and contact information for two-three references, a short description of their research experience, and goals to Yi Shi at ().
- Responsibilities.
- Qualifications.
Employer Description
Strength through Unity and Inclusion
The Mount Sinai Health System is committed to fostering an environment where everyone can contribute to excellence. We share a common dedication to delivering outstanding patient care. When you join us, you become part of Mount Sinai’s unparalleled legacy of achievement, education, and innovation as we work together to transform healthcare. We encourage all team members to actively participate in creating a culture that ensures fair access to opportunities, promotes inclusive practices, and supports the success of every individual.
At Mount Sinai, our leaders are committed to fostering a workplace where all employees feel valued, respected, and empowered to grow. We strive to create an environment where collaboration, fairness, and continuous learning drive positive change, improving the well-being of our staff, patients, and organization.
Our leaders are expected to challenge outdated practices, promote a culture of respect, and work toward meaningful improvements that enhance patient care and workplace experiences. We are dedicated to building a supportive and welcoming environment where everyone has the opportunity to thrive and advance professionally. Explore this opportunity and be part of the next chapter in our history.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek® and No. 7 in the U.S. on the magazine’s 2026 World’s Best Hospitals list and No. 3 in the world in its World’s Best Smart Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 9 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health grant funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Equal opportunity and legal notices
The Mount Sinai Health System is an equal opportunity employer, complying with all applicable federal civil rights laws. We do not discriminate, exclude, or treat individuals differently based on race, color, national origin, age, religion, disability, sex, sexual orientation, gender, veteran status, or any other characteristic protected by law. We are deeply committed to fostering an environment where all faculty, staff, students,...
From Mount Sinai Health System's careers page, posted on January 24, 2022, first listed on Rolev.ai on November 22, 2026. Rolev.ai is not the employer.
How Rolev.ai helps with this application
Rolev.ai is a job search and application tool for US job seekers. For this Postdoctoral Fellow-MSH role at Mount Sinai Health System, it shows how your resume fits, tailors your resume to the posting, and prepares the application for you to review.
See how you fit
Openings from employer career sites are ranked against your whole resume—and searchable inside Claude, ChatGPT, and Cursor via Rolev.ai MCP.
Tailor without inventing
Every change to your resume is checked against your original. New experience goes in only with your yes—zero fabricated claims.
Draft the full kit
Tailored and Full Match resumes, role-specific cover letters, and answers to employer screening questions are prepared in seconds.
1-Click Extension Autofill
The Chrome extension fills the employer's Greenhouse, Workday, Lever, or Ashby form in 1 click. You review it and press Submit.
Similar roles
More at Mount Sinai Health System
All Mount Sinai Health System jobsCommon questions
Where is the Postdoctoral Fellow-MSH job at Mount Sinai Health System located?
This Postdoctoral Fellow-MSH position at Mount Sinai Health System is located in New York, NY. Always check Mount Sinai Health System's application page for specific state eligibility or relocation policies.
How do I apply for the Postdoctoral Fellow-MSH position at Mount Sinai Health System?
This listing links directly to Mount Sinai Health System's application page. You can apply directly on Mount Sinai Health System's site, or use Rolev.ai to check your resume fit, generate a zero-hallucination tailored resume and cover letter for this posting, and autofill the application form in 1 click with the Rolev.ai Chrome extension. You always review the form and press Submit yourself.